Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

NCT00196768 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Acute Promyelocytic Leukemia
Refractory Acute Promyelocytic Leukemia

Interventions

DRUG: Arsenic trioxide
DRUG: Trisenox

Sponsor

German AML Cooperative Group